2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Update on HER2+ mCRC: Did Trastuzumab Deruxtecan Demonstrate Activity in Patients With HER2-Expressing Disease Who Are Refractory to Standard Therapies?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Chloe Atreya
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Chloe Atreya
140 views
August 20, 2020
Comments 0
Login to view comments.
Click here to Login
GI